• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

FORVIA SE

Notes

No. Proposition For Against Abstain
1

Approval of the statutory financial statements for the fiscal year ended December 31, 2025 - Approval of non-tax-deductible expenses and costs

2

Approval of the consolidated financial statements for the fiscal year ended December 31, 2025

3

Appropriation of income for the fiscal year

4

Statutory Auditors' special report on related-party agreements - Acknowledgement that there were no new agreement

5

Appointment of Pierre-Andr de Chalendar as Board member

6

Approval of the information referred to in I of Article L. 22-10-9 of the French Commercial Code - Compensation Report

7

Approval of the elements comprising the total compensation and all benefits of any kind paid during the fiscal year ended December 31, 2025, or granted in respect of the same fiscal year to Michel de Rosen, Chairman of the Board of Directors

8

Approval of the elements comprising the total compensation and all benefits of any kind paid during the fiscal year ended December 31, 2025, or granted in respect of the same fiscal year to Patrick Koller, Chief Executive Officer for the period from January 1, 2025 to February 28, 2025

9

Approval of the elements comprising the total compensation and all benefits of any kind paid during the fiscal year ended December 31, 2025, or granted in respect of the same fiscal year to Martin Fischer, Chief Executive Officer since March 1, 2025

10

Approval of the compensation policy for Board members

11

Approval of the compensation policy for the Chairman of the Board of Directors

12

Approval of the compensation policy for the Chief Executive Officer

13

Authorization to be granted to the Board of Directors to allow the Company to buy back its own shares in accordance with the provisions of Article L. 22-10-62 of the French Commercial Code

14

Delegation of authority to be granted to the Board of Directors to issue shares and/or securities giving access, immediately or in the future, to the share capital of the Company and/or of a Subsidiary and/or debt securities, with preferential subscription rights (suspension during tender offer periods)

15

Delegation of authority to be granted to the Board of Directors to issue shares and/or securities giving access, immediately or in the future, to the share capital of the Company and/or of a Subsidiary and/or debt securities, without preferential subscription rights through public offerings (excluding offers referred to in 1o of Article L. 411-2 of

16

Delegation of authority to be granted to the Board of Directors to issue shares and/or securities giving access, immediately or in the future, to the share capital of the Company and/or of a Subsidiary and/or debt securities, without preferential rights through an offer exclusively targeting a restricted circle of investors acting for their own acc

17

Authorization to increase the amount of issues provided for in the fourteenth, fifteenth and sixteenth resolutions (suspension during tender offer periods)

18

Delegation to be granted to the Board of Directors to issue shares and/or securities giving access, immediately or in the future, to the share capital of the Company, without preferential subscription rights, in order to remunerate contributions in kind of securities granted to the Company (suspension during tender offer periods)

19

Delegation of authority to be granted to the Board of Directors to increase the Company's share capital by capitalization of reserves, profits, premiums or other amounts whose capitalization would be allowed (suspension during tender offer periods)

20

Authorization to be granted to the Board of Directors to grant, for free, existing shares and/or shares to be issued to employees and/or certain corporate officers of the Company or of affiliated companies or economic interest groups, with waiver by the shareholders of their preferential subscription rights

21

Delegation of authority to be granted to the Board of Directors for the purpose of increasing the share capital through the issue of shares and/or securities giving access to the share capital, with removal of preferential subscription rights for the benefit of members of a company or group savings plan

22

Delegation of authority to be granted to the Board of Directors in order to carry out share capital increases, with removal of preferential subscription rights in favor of categories of beneficiaries

23

Authorization to be granted to the Board of Directors for the purpose of reducing the share capital through the cancellation of shares in accordance with the provisions of Article L. 22-10-62 of the French Commercial Code

24

Amendment of Article 11 of the bylaws to provide for the staggering of Board members' terms of office

25

Amendment of Article 13 of the bylaws to remove the exceptional reference relating to Board Observers

26

Powers for formalities